ImmunologybioRxivPreprint
TRAIL-mediated PMN-MDSC depletion prevents CD4+ T cell loss in HIV-infectedhumanized mice
Shawn A. Abeynaike, Kayla Frank, Angel Gandarilla, Silke Paust
This study shows that TRAIL-R2 agonist treatment reduces MDSCs in HIV-infected mice, prevents CD4+ T cell loss, and enhances immune function.
1 citation